Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Systemic Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03894007
What this trial is testing

Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer

Who this might be right for
Early-stage Breast CancerHER2-positive Breast Cancer
Renske Altena 6
Testing effectiveness (Phase 2)Looking for participantsNCT07340463
What this trial is testing

The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Nanjing University School of Medicine 50
Not applicableStudy completedNCT00161265
What this trial is testing

Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

Who this might be right for
Breast Cancer
University of Michigan Rogel Cancer Center 68
Post-approval studies (Phase 4)Looking for participantsNCT05207358
What this trial is testing

Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Institutul Clinic Fundeni 30
Not applicableUnknownNCT05151224
What this trial is testing

Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma

Who this might be right for
Breast Carcinoma
Ain Shams University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06949111
What this trial is testing

Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）

Who this might be right for
Colon Cancer
Hebei Medical University Fourth Hospital 128
Not applicableLooking for participantsNCT06140134
What this trial is testing

Liver Transplantation in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCholangiocarcinoma, Intrahepatic
Rutgers, The State University of New Jersey 30
Not applicableStudy completedNCT06326619
What this trial is testing

Survival Benefit of Primary Tumour Resection Compared to Systemic Therapy Alone in Stage IV Colorectal Cancer Patients

Who this might be right for
Colorectal CancerNeoadjuvant Systemic Therapy
Medizinische Hochschule Brandenburg Theodor Fontane 480
Testing effectiveness (Phase 2)Looking for participantsNCT07222657
What this trial is testing

Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaEsophageal Cancer
Case Comprehensive Cancer Center 40
Not applicableLooking for participantsNCT06681064
What this trial is testing

Breast Cancer Evolution During Neoadjuvant Systemic Therapy

Who this might be right for
Breast CancerTriple Negative Breast CancerER+ Breast Cancer+1 more
Royal Marsden NHS Foundation Trust 500
Not applicableStudy completedNCT06149377
What this trial is testing

Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer

Who this might be right for
Breast CancerSentinel Lymph Node
Fujian Medical University Union Hospital 716
Not applicableLooking for participantsNCT05416164
What this trial is testing

DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 595
Not applicableActive Not RecruitingNCT04101851
What this trial is testing

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST

Who this might be right for
Breast Cancer FemaleBreast Cancer
Toralf Reimer, MD PhD 350
Not applicableNot Yet RecruitingNCT07819981
What this trial is testing

Prehabilitation for Improving Outcomes in Breast Cancer Patients Undergoing Neoadjuvant Systemic Treatment and Surgery

Who this might be right for
Breast Carcinoma
City of Hope Medical Center 20
Not applicableNot Yet RecruitingNCT07675291
What this trial is testing

Rituximab Combining With Low-Dose Mycophenolate Mofetil on Proliferative Lupus Nephritis in Children

Who this might be right for
Lupus Nephritis
Nanfang Hospital, Southern Medical University 112
Post-approval studies (Phase 4)Study completedNCT02645565
What this trial is testing

Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Jawaharlal Institute of Postgraduate Medical Education & Research 75
Large-scale testing (Phase 3)UnknownNCT01204801
What this trial is testing

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Who this might be right for
Breast Cancer
Medifocus, Inc. 238
Not applicableLooking for participantsNCT05939830
What this trial is testing

Omission of ALND in Breast Cancer Patients With Axillary pCR

Who this might be right for
Axillary Lymph Node DissectionPathological Complete ResponseNeoadjuvant Systemic Therapy+2 more
The First Affiliated Hospital with Nanjing Medical University 92
Large-scale testing (Phase 3)Active Not RecruitingNCT01996267
What this trial is testing

Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2

Who this might be right for
Breast CancerHER2 Positive
The Netherlands Cancer Institute 437
Testing effectiveness (Phase 2)Looking for participantsNCT07407920
What this trial is testing

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Early Stage HER2-Positive Breast Carcinoma+1 more
M.D. Anderson Cancer Center 120
Next Page